|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0038952,
umls-concept:C0087111,
umls-concept:C0184511,
umls-concept:C0205174,
umls-concept:C0247025,
umls-concept:C0332257,
umls-concept:C0332281,
umls-concept:C0522523,
umls-concept:C1274040,
umls-concept:C1521840,
umls-concept:C1522318,
umls-concept:C1948041,
umls-concept:C2348205
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2003-10-2
|
|
pubmed:abstractText |
We sought to examine if clopidogrel treatment initiated before coronary stenting improved clinical outcomes among patients receiving aspirin and a glycoprotein (GP) IIb/IIIa inhibitor.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Aspirin,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin Fab Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Platelet Aggregation Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Platelet Glycoprotein GPIIb-IIIa...,
http://linkedlifedata.com/resource/pubmed/chemical/Ticlopidine,
http://linkedlifedata.com/resource/pubmed/chemical/Tyrosine,
http://linkedlifedata.com/resource/pubmed/chemical/abciximab,
http://linkedlifedata.com/resource/pubmed/chemical/clopidogrel,
http://linkedlifedata.com/resource/pubmed/chemical/tirofiban
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0735-1097
|
|
pubmed:author |
pubmed-author:BergerPeter BPB,
pubmed-author:BhattDeepak LDL,
pubmed-author:ChanAlbert WAW,
pubmed-author:DiBattistePeter MPM,
pubmed-author:MoliternoDavid JDJ,
pubmed-author:SappShelly KSK,
pubmed-author:StoneGregg WGW,
pubmed-author:TARGET Investigators,
pubmed-author:TopolEric JEJ,
pubmed-author:WolskiKathyK,
pubmed-author:YakubovSteven LSL
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
42
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1188-95
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:14522478-Angioplasty, Balloon, Coronary,
pubmed-meshheading:14522478-Antibodies, Monoclonal,
pubmed-meshheading:14522478-Aspirin,
pubmed-meshheading:14522478-Combined Modality Therapy,
pubmed-meshheading:14522478-Drug Administration Schedule,
pubmed-meshheading:14522478-Drug Therapy, Combination,
pubmed-meshheading:14522478-Female,
pubmed-meshheading:14522478-Humans,
pubmed-meshheading:14522478-Immunoglobulin Fab Fragments,
pubmed-meshheading:14522478-Louisiana,
pubmed-meshheading:14522478-Male,
pubmed-meshheading:14522478-Middle Aged,
pubmed-meshheading:14522478-Minnesota,
pubmed-meshheading:14522478-Myocardial Infarction,
pubmed-meshheading:14522478-New York City,
pubmed-meshheading:14522478-Ohio,
pubmed-meshheading:14522478-Pennsylvania,
pubmed-meshheading:14522478-Platelet Aggregation Inhibitors,
pubmed-meshheading:14522478-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:14522478-Postoperative Care,
pubmed-meshheading:14522478-Premedication,
pubmed-meshheading:14522478-Severity of Illness Index,
pubmed-meshheading:14522478-Stents,
pubmed-meshheading:14522478-Survival Analysis,
pubmed-meshheading:14522478-Ticlopidine,
pubmed-meshheading:14522478-Treatment Outcome,
pubmed-meshheading:14522478-Tyrosine
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET).
|
|
pubmed:affiliation |
Department of Cardiology, Ochsner Clinic Foundation, New Orleans, Louisiana, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
